Implantatsioonijärgne

Implantatsioonijärgne refers to the period following the implantation of an embryo into the uterine wall during assisted reproductive technologies (ART) such as in vitro fertilization (IVF). This phase is crucial for the successful establishment of a pregnancy. It begins after the embryo transfer and continues until a pregnancy can be confirmed, typically through a pregnancy test measuring human chorionic gonadotropin (hCG).

During the implantatsioonijärgne period, the woman's body is monitored for signs of implantation and early pregnancy. The embryo, now attached to the uterine lining, begins to develop and secrete hCG. This hormone is detectable in the blood and urine and serves as the primary indicator of pregnancy. The duration of this period can vary, but it generally lasts about two weeks from the embryo transfer date.

Emotional and physical well-being are important during this time. Many clinics provide support and guidance to patients, advising on rest, nutrition, and avoiding strenuous activities. The success of implantation depends on various factors, including the quality of the embryo, the receptivity of the uterine lining, and the overall health of the woman. The implantatsioonijärgne phase is often characterized by anticipation and anxiety for the individuals undergoing fertility treatment, as they await confirmation of a viable pregnancy. Further monitoring may follow a positive pregnancy test to ensure the pregnancy is progressing normally.